Colgate-Palmolive vs URSAPHARM

Amazon turns Thursday Night Football into full-funnel ad pitch

Amazon's Thursday Night Football (TNF) has become a key pitch for attracting both endemic and non-endemic advertisers to its broader advertising ecosystem. The platform leverages Prime Video's sports inventory, combined with Amazon's data and targeting capabilities, to offer full-funnel marketing opportunities. Advertisers like Colgate-Palmolive have seen significant success, with retargeting on Amazon's retail platform driving higher purchase rates and brand awareness. Media buyers note that TNF serves as a gateway for brands to increase spending on Amazon's DSP. Endemic brands appreciate the direct connection between ad exposure and sales data, while non-endemics use TNF to test Amazon's capabilities before expanding their media budgets. Amazon's strategy includes promoting multi-sport buys and upper/lower funnel inventory, aiming to raise ad spending ceiling among advertisers.

• Amazon's TNF has seen a 6% increase in advertisers this season and has brought over 80 brands new to TNF since 2022.
• Colgate-Palmolive re-upped its TNF partnership after a campaign with Bijan Robinson drove purchase rates up 8 times and doubled branded searches.
• TNF's week four game (Steelers-Browns) was the most-watched in history with 19% higher audience than 2025's comparable game.

10-Q Financial Filing Analysis for Colgate-Palmolive (2026-07-31)

Colgate-Palmolive reported second-quarter 2026 net sales of $5.361 billion, up 4.9% year-over-year, supported by 0.9% volume growth, 1.6% pricing gains, and a 2.4% favorable foreign exchange impact (organic sales growth reached 2.4%). GAAP operating profit declined 6.0% to $1.016 billion, weighed down by $129 million in pre-tax restructuring charges tied to the expanded Strategic Growth and Productivity Program. Excluding these charges, non-GAAP operating profit rose 5.0% to $1.145 billion with a 10 bps expansion in non-GAAP operating margin to 21.4%. Diluted earnings per share decreased to $0.86 on a GAAP basis (down from $0.91), while non-GAAP diluted EPS grew 8.0% to $0.99. Strong gross margin expansion (+140 bps to 61.5%) driven by funding-the-growth cost savings (280 bps) helped fund a 15% increase in advertising investment to $777 million. The company generated $1.742 billion in operating cash flow for the first six months of 2026 and continues to execute its $5.0 billion share repurchase program alongside regular dividend distributions.

• Q2 2026 net sales reached $5.361 billion (up 4.9% YoY; organic sales up 2.4%), with gross margin expanding 140 bps to 61.5%.
• GAAP operating profit was $1.016 billion and diluted EPS was $0.86, while non-GAAP operating profit rose 5% to $1.145 billion and non-GAAP diluted EPS reached $0.99.
• Cumulative pre-tax charges under the Strategic Growth and Productivity Program reached $318 million through June 30, 2026, targeting $200 million to $300 million in annualized savings.

Colgate-Palmolive Webcasts Fireside Chat at the Barclays 2026 Global Consumer Staples Conference

NEW YORK --(BUSINESS WIRE)--Aug. 27, 2026-- Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, will participate in a fireside chat on Wednesday, September 9, 2026 at 8:15 a.m. ET at the Barclays 2026 Global Consumer Staples Conference.

URSAPHARM und der FC Bayern bauen erfolgreiche Partnerschaft weiter aus

Die URSAPHARM Arzneimittel GmbH und der FC Bayern München setzen ihre erfolgreiche Zusammenarbeit fort. Mit HYLO®, dem marktführenden Sortiment im Bereich der Befeuchtung trockener Augen, bleibt URSAPHARM bis 2029 Gold Partner der ersten Herrenmannschaft des deutschen Rekordmeisters. Gleichzeitig wird die Partnerschaft strategisch ausgebaut: Neben einer stärkeren Ausrichtung auf die asiatischen Märkte […]